Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06545799

Construction of a Cohort for Pan-Vascular Disease Among Employees of Taizhou People's Hospital

1. Participant Recruitment During the annual health check-ups for hospital staff, potential participants are recruited. Those who express interest are provided with a detailed explanation of the study's objectives, content, and procedures, and are required to sign an informed consent form. 2. Screening Phase Medical history is collected, including any previous occurrences of myocardial infarction, ischemic or hemorrhagic stroke, or history of coronary, carotid, or peripheral arterial revascularization. 3. Baseline Data Collection

1. Health Questionnaire Survey: Collect demographic information, medical history, and data on nutrition, physical activity, and smoking habits through a questionnaire.

2. Clinical Assessments: Conduct the following assessments for all enrolled participants:

* High-sensitivity cardiac troponin I and NT-proBNP testing * Non-invasive arterial stiffness testing * Measurement of visceral and subcutaneous fat content * Fundus photography * Body composition analysis

4 Regular Follow-Up

Annual follow-up for a total of 10 years. The follow-up includes:

1. . Collection of updated demographic information and medical history, as well as repeated questionnaires on nutrition, physical activity, and smoking habits. 2. . Reassessment of the following items:

* High-sensitivity cardiac troponin I and NT-proBNP testing * Non-invasive arterial stiffness testing * Measurement of visceral and subcutaneous fat content * Fundus photography * Body composition analysis

5 Outcome Evaluation

1). Primary Outcomes: Cardiovascular mortality, non-fatal myocardial infarction, or non-fatal stroke events.

2). Secondary Outcomes: All vascular events, changes in cardiovascular biomarkers, and degree of arterial stiffness.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Employed or retired individuals aged 45 years or older;
  • Willing to sign an informed consent form and voluntarily participate in health examinations and related data collection.

Exclusion criteria

  • History of myocardial infarction, ischemic or hemorrhagic stroke, or revascularization of coronary, carotid, or peripheral arteries;
  • Employees with severe psychological disorders who are unable to cooperate with the study;
  • Pregnant or breastfeeding women.

Treatment and study plan

Primary outcomes

  1. Cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke events

    Time frame: September 2024 to August 2034

    Cardiovascular death: Death from heart or blood vessel diseases.

    Non-fatal myocardial infarction: Heart attack that does not result in death.

    Non-fatal stroke events: Stroke incidents that do not result in death.

Study contacts

Contact information is provided by the study sponsor or research team.

Qingqing Zhang

CONTACT

[email protected]

+86 180 6198 6120

Sponsors and collaborators

Lead sponsor

Jiangsu Taizhou People's Hospital

Other

Registry information

Important dates

Study start
2024
Primary completion
2034
Study completion
2034
First posted
Aug 9, 2024
Registry last updated
Aug 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.